Financing, Equity Capital Markets
Marker Therapeutics, Inc.
03/21
|
$56.5 Million
![](/sites/default/files/images/custom/marker-therapeutics-inc.png)
Piper Sandler served as sole bookrunner for Marker Therapeutics, Inc. on a confidentially marketed follow-on offering